Soleno therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Redwood city, calif., aug. 19, 2024 (globe newswire) -- soleno therapeutics, inc. (“soleno”) (nasdaq: slno), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by nasdaq stock market rules, the grant of inducement awards to six new employees.
NDAQ Ratings Summary
NDAQ Quant Ranking